NEWS & EVENTS
22. 3. 30.
Dr. Sun Kim was invited to serve on the IEEE/ACM TCBB Steering Committee as an ACM representative.
Dr. Sun Kim was invited to serve on the IEEE/ACM Transactions on Computational Biology and Bioinformatics (TCBB) Steering Committee as an Association for Computing Machinery (ACM) representative from January 1, 2022.
Dr. Sun Kim’s work on DL modeling of GPCR protein family hierarchy was selected by Faculty Opinions
Dr. Sun Kim’s work on deep learning modeling of GPCR protein family hierarchy was selected by Faculty Opinions.
Dr. Sun Kim was awarded prestigious “Ilchun Memorial Lecture”.
Dr. Sun Kim was awarded prestigious “Ilchun Memorial Lecture” and gave a lecture “Modern AI Technologies: Innovative Toolkits for the Investigation of Fundamental Questions in Molecular Biology” at the international conference, organized by the Korean Society for Molecular and Cellular Biology (KSMCB) 2021.
Initiated a new project 'AI platform for drug toxicity' in collaboration with Seoul National University
On August 25, 2021, AIgenDrug signed an MoU with three experts at Seoul National University for the development and deployment of an AI drug toxicity prediction model.
Welcome Dr. Sunho Lee, our new CTO
AIgenDrug is proud to announce that Dr. Sunho Lee takes the role of Vice President and Chief Technology Officer (CTO). He will lead the company’s technical strategy and business development for AI drug discovery.